Trabectedin derivative 2 (TFA)
Trabectedin derivative 2 TFA (compound PL-12) is a Trabectedin derivative that can be used for the study of cancer[1].
Product Specifications
UNSPSC
12352211
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Purity
99.78
Solubility
DMSO : 100 mg/mL
Smiles
N#C[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](CO4)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@](C8=CC=C9N)(NCCC8=C9)C4=O)([H])C5=C7OC(C)=O.O=C(O)C(F)(F)F
Molecular Formula
C41H42F3N5O10S
Molecular Weight
853.86
References & Citations
[1]Bin Zou, et al. Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives. WO2024186264A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
